10-year analysis of human immunodeficiency virus incidence in first-time and repeat donors in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
PREISS, Liliana
GONCALEZ, Thelma T.
OLIVEIRA, Claudia Di Lorenzo
GREBE, Eduard
GERMANIO, Clara Di
STONE, Mars
AMORIM FILHO, Luiz
PROIETTI, Anna Barbara Carneiro
BELISARIO, Andre Rolim
Citação
VOX SANGUINIS, v.116, n.2, p.207-216, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and objectives Incidence in first-time and repeat blood donors is an important measure of transfusion-transmitted HIV infection (TT-HIV) risk. This study assessed HIV incidence over time at four large blood centres in Brazil. Materials and methods Donations were screened and confirmed using serological assays for HIV from 2007 to 2016, and additionally screened by nucleic acid testing from 2011 forward. Limiting antigen (LAg) avidity testing was conducted on HIV seroreactive samples from first-time donors to classify whether an infection was recently acquired. We calculated incidence in first-time donors using the mean duration of recent infection and in repeat donors using classical methods. Time and demographic trends were assessed using Poisson regression. Results Over the 10-year period, HIV incidence in first-time donors was highest in Recife (45 center dot 1/100 000 person-years (10(5)py)) followed by Sao Paulo (32 center dot 2/10(5)py) and then Belo Horizonte (23 center dot 3/10(5)py), and in repeat donors was highest in Recife (33 center dot 2/10(5)py), Belo Horizonte (27 center dot 5/10(5)py) and Sao Paulo (17 center dot 0/10(5)py). Results from Rio de Janeiro were available from 2013 to 2016 with incidence in first-time donors of 35 center dot 9/10(5)py and repeat donors from 2011 to 2016 of 29 center dot 2/10(5)py. Incidence varied by other donor demographics. When incidence was considered in 2-year intervals, no significant trend was evident. Overall residual risk of TT-HIV was 5 center dot 46 and 7 center dot 41 per million units of pRBC and FFP transfused, respectively. Conclusion HIV incidence in both first-time and repeat donors varied by region in Brazil. Clear secular trends were not evident.
Palavras-chave
blood safety, donors, residual risk estimation, serological testing, transfusion- transmissible infections
Referências
  1. an der Heiden M, 2015, VOX SANG, V108, P123, DOI 10.1111/vox.12204
  2. ANVISA: Agencia Nacional de Vigilancia Sanitaria, 2018, ANVISA PROD HEMOTERA
  3. Brambilla DJ, 2017, TRANSFUSION, V57, P823, DOI 10.1111/trf.13939
  4. Bruhn R, 2013, TRANSFUSION, V53, P2399, DOI 10.1111/trf.12299
  5. Busch MP, 1996, TRANSFUS CLIN BIOL, V3, P7, DOI 10.1016/S1246-7820(96)80007-3
  6. Carneiro-Proietti ABF, 2012, AIDS RES HUM RETROV, V28, P1265, DOI 10.1089/aid.2011.0143
  7. Corporation SB, 2018, SED HIV 1 LAG AV EIA, V1, P1
  8. Neto CD, 2012, TRANSFUSION, V52, P722, DOI 10.1111/j.1537-2995.2011.03358.x
  9. Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947
  10. Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005
  11. Keating SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222290
  12. Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08
  13. Moreno EC, 2019, HEMATOL TRANSF CELL, V41, P229, DOI 10.1016/j.htct.2018.11.002
  14. Vieira PCM, 2017, TRANSFUSION, V57, P1968, DOI 10.1111/trf.14146
  15. O'Brien SF, 2017, TRANSFUS APHER SCI, V56, P389, DOI 10.1016/j.transci.2017.03.010
  16. Oliveira CDL, 2013, VOX SANG, V104, P100, DOI 10.1111/j.1423-0410.2012.01643.x
  17. Pillonel J, 2005, Euro Surveill, V10, P5
  18. Rocha D, 2018, TRANSFUSION, V58, P862, DOI 10.1111/trf.14478
  19. Sabino EC, 2012, TRANSFUSION, V52, P870, DOI 10.1111/j.1537-2995.2011.03344.x
  20. Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
  21. Truong HHM, 2015, AIDS BEHAV, V19, P1574, DOI 10.1007/s10461-015-1036-8
  22. Velati C, 2018, BLOOD TRANSFUS-ITALY, V16, P422, DOI 10.2450/2018.0069-18
  23. Vermeulen M, 2019, TRANSFUSION, V59, P267, DOI 10.1111/trf.14959
  24. Weusten J, 2011, TRANSFUSION, V51, P203, DOI 10.1111/j.1537-2995.2010.02804.x
  25. World Health Organization, 2019, BLOOD SAF AV